CSL Limited (ASX: CSL) is Australia’s largest (and some might say best) healthcare company, specialising in biopharmaceuticals. Founded in the late 1900s as the Commonwealth Serum Laboratories, CSL was sold by the Australian Government to Australian investors via the share market in 1994 at $2.30 per share, at which time it doubled its size through an international acquisition. CSL is a global leader in blood plasma vaccines (think: the flu) and antivenoms, providing relief for potentially life-threatening medical conditions.
BHP Group’s Chief Financial Officer David Lamont sat down with Chief Investment Officer Owen Rask to discuss BHP’s past, present and future.
The Resmed CDI (ASX:RMD) share price is down around 14.9% since the start of the 2023. It’s probably worth asking, ‘is the RMD share price top value?’
The CSL Limited (ASX:CSL) share price has decreased 1.1% since the start of the 2023. It’s probably worth asking, ‘is the CSL share price good value?’
The mood was distinctly positive on the trading screens, with the benchmark S&P/ASX 200 (INDEXASX: XJO) index putting on 120.1 points, or 1.7 per cent, to 7,377.9, while the broader All Ordinaries (INDEXASX: XAO) rose 130.3 points, also 1.7 per cent, to 7,599.4.
Australia’s share market pushed higher on Wednesday, as the big miners tracked iron ore prices higher. At the close the S&P/ASX 200 (INDEXASX: XJO) was up 23.8 points, or 0.3 per cent, to 7,259.1 points, while the broader All Ordinaries (INDEXASX: XAO) index gained 22.7 points, also 0.3 per cent, to 7,469.1.
The Resmed CDI (ASX:RMD) share price has decreased 16.4% since the start of the 2023. It’s probably worth asking, ‘is the RMD share price good value?’
The benchmark S&P/ASX 200 (INDEXASX: XJO) index added 36.3 points, or 0.5 per cent, to 7,235.3 points at the close. The broader All Ordinaries (INDEXASX: XAO) rose 36.2 points, or 0.5 per cent, to 7,446.4.
The benchmark S&P/ASX 200 (INDEXASX: XJO) index ending the session 4.1 points to the good, at 7,199, while the broader All Ordinaries (INDEXASX: XAO) edged 4.6 points into the green, to 7,410.2.
The CSL Limited (ASX:CSL) share price is down around 5.0% since the start of the 2023. It’s probably worth asking, ‘is the CSL share price top value?’
